NCT05242965View on ClinicalTrials.gov

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

August 13, 2024

Study Completion Date

December 31, 2026

Conditions
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
Interventions
BIOLOGICAL

CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine

Given ID

BIOLOGICAL

Sargramostim

Given ID

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Biopsy

Undergo biopsy

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

Trial Locations (2)

98108

VA Puget Sound Health Care System, Seattle

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of Washington

OTHER